Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Net Income: 2019-2024

Historic Net Income for Keros Therapeutics (KROS) over the last 6 years, with Dec 2024 value amounting to -$187.4 million.

  • Keros Therapeutics' Net Income rose 86.25% to -$7.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.4 million, marking a year-over-year increase of 134.32%. This contributed to the annual value of -$187.4 million for FY2024, which is 22.46% down from last year.
  • As of FY2024, Keros Therapeutics' Net Income stood at -$187.4 million, which was down 22.46% from -$153.0 million recorded in FY2023.
  • In the past 5 years, Keros Therapeutics' Net Income registered a high of -$45.4 million during FY2020, and its lowest value of -$187.4 million during FY2024.
  • Over the past 3 years, Keros Therapeutics' median Net Income value was -$153.0 million (recorded in 2023), while the average stood at -$148.3 million.
  • Data for Keros Therapeutics' Net Income shows a maximum YoY crashed of 267.71% (in 2020) over the last 5 years.
  • Over the past 5 years, Keros Therapeutics' Net Income (Yearly) stood at -$45.4 million in 2020, then decreased by 29.50% to -$58.7 million in 2021, then crashed by 78.20% to -$104.7 million in 2022, then crashed by 46.15% to -$153.0 million in 2023, then declined by 22.46% to -$187.4 million in 2024.